ConclusionsResults of 2-year rat study

• Teriparatide causes osteoblast neoplasms

• Tumor induction is dependent on dose and treatment duration

• No-effect-dose was not established

• Teriparatide increases bone mass

Previous slide

Next slide

Back to first slide

View graphic version